Hostname: page-component-76d6cb85b7-hqrjx Total loading time: 0 Render date: 2026-07-25T13:11:40.381Z Has data issue: false hasContentIssue false

Comparison of quality of life in vestibular schwannoma patients managed with observation, radiotherapy or microsurgery

Published online by Cambridge University Press:  16 April 2024

Jessica F Ball*
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Lister Hospital, Stevenage, UK
Jacob C M Low
Affiliation:
Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, UK
Anand V Kasbekar
Affiliation:
Nottingham University Hospitals NHS Trust & Hearing Sciences, University of Nottingham, Nottingham, UK
Tristram H Lesser
Affiliation:
Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
*
Corresponding author: Jessica F Ball; Email: jessicaball@nhs.net

Abstract

Objectives

In decision making regarding the management of vestibular schwannomas, alongside clinical outcomes, an understanding of patient reported health-related quality of life measures is key. Therefore, the aim of this research is to compare health-related quality of life in vestibular schwannoma patients treated with active observation, stereotactic radiotherapy and microsurgical excision.

Methods

A cross-sectional study of patients diagnosed with unilateral sporadic vestibular schwannomas between 1995 and 2015 at a specialist tertiary centre was conducted. Patients completed the Penn Acoustic Neuroma Quality of Life questionnaire and handicap inventories for dizziness, hearing and tinnitus.

Results

Of 234 patients, 136 responded (58.1 per cent). Management modality was: 86 observation, 23 stereotactic radiotherapy and 25 microsurgery. Females reported significantly worse dizziness; males reported significantly worse physical disability. Patients less than 65 years old reported significantly worse tinnitus and pain scores. Overall, quality of life was higher in the observation group.

Conclusion

Conservative management, where appropriate, is favourable with higher quality-of-life outcomes in this cohort. This must be weighed against the risks of a growing tumour.

Information

Type
Main Article
Copyright
Copyright © The Author(s), 2024. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable